Toll-like receptor 9: trafficking and signaling
Toll 样受体 9:运输和信号转导
基本信息
- 批准号:8197148
- 负责人:
- 金额:$ 33.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdjuvantAffectAllergic DiseaseAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-LymphocytesBiological AssayBypassCarbohydratesCell FractionationCellsCommunicable DiseasesCytoplasmic TailDNADataDendritic CellsDevelopmentDiscriminationDominant-Negative MutationEndocytosisEndoplasmic ReticulumEndosomesEventGoalsGolgi ApparatusImmune responseImmune systemIn VitroInterphase CellKnowledgeLysineLysosomesMalignant NeoplasmsMass Spectrum AnalysisMethodsModelingModificationMolecularMovementMutateNucleic AcidsPathologyPathway interactionsPatternPeptide HydrolasesPhosphorylationPlayPost-Translational Protein ProcessingProteinsReceptors, Antigen, B-CellRegulationRoleSecretory CellSignal TransductionSiteSmall Interfering RNASystemic Lupus ErythematosusTLR9 geneTestingTherapeuticTyrosineUbiquitinUbiquitinationVaccinesbasemicrobialmicroorganismmutantnovelreceptorresponsesynergismtrafficking
项目摘要
ABSTRACT
DNA containing CpG motifs (CpG DNA) has incredible potential to treat cancer, infectious and allergic
diseases. Despite this potential, response to our own nucleic acids, including DNA, triggers autoimmune
diseases such as systemic lupus erythematosus. Localization and trafficking of the specific receptor, TLR9,
may play a key role in self/foreign DNA discrimination. Uncovering the molecular mechanisms of TLR9
trafficking is the first step towards our long term goal of manipulating TLR9 trafficking to achieve
modulation of CpG DNA response. We have shown that TLR9 is localized intracellularly, predominantly in
the endoplasmic reticulum (ER), prior to CpG DNA stimulation. TLR9 traffics from the ER to endosomes and
lysosomes where it co-localizes with endocytosed CpG DNA. These data raise the fundamental questions of
what regulates TLR9 access to CpG DNA and how does access affect response to self and microbial DNA?
Using new TLR9 trafficking assays, we have accumulated evidence that TLR9 constitutively exits the ER, that
CpG DNA induces a secondary TLR9 trafficking event, and that both events occur through traditional cell
trafficking pathways. Therefore, we hypothesize that TLR9 constitutively traffics in a highly
regulated fashion through the cell secretory pathway from the Golgi complex to
endolysosomes and that Golgi transit is a prerequisite for TLR9 response to CpG DNA. We
believe that TLR9 trafficking may account for synergy with other TLRs and the autoimmune B
cell receptor, and is regulated by post-translational modification of the TLR9 cytoplasmic tail.
This hypothesis will be tested in three Specific Aims. First, transfected and endogenous TLR9 trafficking
through the Golgi complex will be examined using multiple in vitro approaches including a novel protease
cleavage assay. Second, we will examine the mechanism of TLR9-autoimmune B cell receptor synergism.
Third, we will determine the role of TLR9 post-translational modification in regulating intracellular
trafficking and in TLR-autoimmune B cell receptor synergy. By understanding the mechanism of TLR9
trafficking we can uncover how regulation of response to foreign DNA and lack of response to self-DNA is
achieved. This knowledge will provide the basis for the further development of CpG DNA as an adjuvant and
therapeutic as well as develop mechanisms to interrupt the cycle of autoimmune pathology.
摘要
含CpG基序的DNA(CpG DNA)具有治疗癌症、传染病和过敏性疾病的巨大潜力
疾病尽管有这种潜力,对我们自己的核酸,包括DNA的反应,触发自身免疫
系统性红斑狼疮等疾病。特异性受体TLR 9的定位和运输,
可能在自身/外源DNA辨别中起关键作用。揭示TLR 9的分子机制
贩运是我们操纵TLR 9贩运以实现长期目标的第一步。
CpG DNA反应的调节。我们已经证明TLR 9定位于细胞内,主要在
内质网(ER),在CpG DNA刺激之前。TLR 9从ER运输到内体,
在溶酶体中与内吞的CpG DNA共定位。这些数据提出了以下基本问题:
什么调控TLR 9进入CpG DNA,以及进入如何影响对自身和微生物DNA的反应?
使用新的TLR 9运输测定,我们已经积累了TLR 9组成型退出ER的证据,
CpG DNA诱导了二次TLR 9运输事件,这两个事件都是通过传统的细胞内
贩运途径。因此,我们假设TLR 9组成性地以高度依赖性的方式运输。
调节方式通过细胞分泌途径从高尔基复合体,
内溶酶体和高尔基体转运是TLR 9应答CpG DNA的先决条件。我们
我相信TLR 9的运输可能与其他TLRs和自身免疫性B协同作用
细胞受体,并通过TLR 9胞质尾区的翻译后修饰进行调节。
这一假设将在三个具体目标中得到检验。首先,转染的和内源性的TLR 9运输
通过高尔基复合体将使用多种体外方法,包括一种新的蛋白酶,
裂解测定其次,我们将研究TLR 9-自身免疫B细胞受体协同作用的机制。
第三,我们将确定TLR 9的翻译后修饰在调节细胞内信号转导中的作用。
运输和TLR-自身免疫B细胞受体协同作用。通过了解TLR 9的机制,
我们可以揭示如何调节对外来DNA的反应和缺乏对自身DNA的反应,
办妥了一批这些知识将为进一步开发CpG DNA作为佐剂提供基础,
治疗以及开发机制,中断自身免疫病理循环。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYNTHIA A LEIFER其他文献
CYNTHIA A LEIFER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYNTHIA A LEIFER', 18)}}的其他基金
Role of TLR9 in infection and host response to HHV-6A
TLR9 在 HHV-6A 感染和宿主反应中的作用
- 批准号:
8823158 - 财政年份:2014
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9 proteolytic processing and signaling
Toll 样受体 9 蛋白水解加工和信号转导
- 批准号:
8463979 - 财政年份:2012
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9 proteolytic processing and signaling
Toll 样受体 9 蛋白水解加工和信号转导
- 批准号:
8382948 - 财政年份:2012
- 资助金额:
$ 33.96万 - 项目类别:
The innate Immune Response to Mousepox at the Site - Associated Project
现场对鼠痘的先天免疫反应 - 相关项目
- 批准号:
7982868 - 财政年份:2009
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9: trafficking and signaling
Toll 样受体 9:运输和信号转导
- 批准号:
7922302 - 财政年份:2009
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9: trafficking and signaling
Toll 样受体 9:运输和信号转导
- 批准号:
8384885 - 财政年份:2008
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9: trafficking and signaling
Toll 样受体 9:运输和信号转导
- 批准号:
7590563 - 财政年份:2008
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9: trafficking and signaling
Toll 样受体 9:运输和信号转导
- 批准号:
7988577 - 财政年份:2008
- 资助金额:
$ 33.96万 - 项目类别:
Toll-like receptor 9: trafficking and signaling
Toll 样受体 9:运输和信号转导
- 批准号:
7742607 - 财政年份:2008
- 资助金额:
$ 33.96万 - 项目类别:
Enhancing Immunotherapy through Toll Like Receptors
通过 Toll 样受体增强免疫治疗
- 批准号:
7288368 - 财政年份:2005
- 资助金额:
$ 33.96万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.96万 - 项目类别:
Research Grant